Witness Testimony

Dr. Gregory Chan, a family and emergency physician in Ponoka, Alberta, testified that he began systematically asking patients about recent COVID-19 injections when they presented with new symptoms, and ultimately submitted 56 adverse event reports through Alberta’s Adverse Events Following Immunization (AEFI) system. He stated that initial reporting through the federal CAEFISS portal was technically difficult, and that after switching to the provincial AEFI system he received feedback on approximately half of his submissions, most of which were rejected. In several cases, including instances involving chest pain, neurological symptoms, and exercise intolerance, he reported being advised that patients should proceed with additional doses despite his clinical concerns.
He described specific cases including a young competitive athlete who became unconscious and developed prolonged exercise intolerance after vaccination, a nurse with unilateral numbness lasting months, and an officer with persistent chest pain. Dr. Chan expressed low confidence in the provincial adverse event review process, stating that criteria appeared inconsistent and that he was instructed to review submission standards after filing reports. He also testified that the four-week reporting window appeared arbitrary and that causation determinations were made without transparent criteria.
Dr. Chan further testified regarding the case of a 14-year-old patient with terminal glioblastoma who was publicly described as Alberta’s first pediatric COVID-19 death, despite COVID not being listed on the death certificate or discharge summary following consultation with the Medical Examiner’s office. He also described a stillbirth occurring approximately eight weeks after maternal vaccination, and his unsuccessful efforts over more than a year to obtain laboratory testing of placental tissue for spike protein expression within Alberta. In his prenatal practice, he stated that he relied on publicly available data to counsel patients on relative risk and emphasized informed consent discussions regarding vaccination during pregnancy.